RGEN Repligen Corp

Repligen Corp is a bioprocessing company developing, producing and commercializing biologic drugs. The company offers its products to life science companies, global biopharmaceutical companies, and contract manufacturers worldwide.

$212.54  -9.19 (-4.15%)
As of 03/02/2021 15:59:54 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Large cap
Health Care
Medical Instruments & Supplies
USA
USA
03/05/2001
52,619,271
338,403
$11,667,270,959
0.00%
SEC Edgar Online
10-Q
10-K
759916109
US7599161095
2731654

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
194.69
7.94
31.86
3.92%
16.36%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy